Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | GALR3 | O60755 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | PIM1 | P11309 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.45 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18934539 | 0.91 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDGAAGALR3 | |
| SCHEMBL22560836 | 0.88 | AR (0.51) | ALDH1A1KDM4EHPGDGAAGALR3 | |
| SCHEMBL23606173 | 0.87 | AR (0.55) | ALDH1A1KDM4EHPGDGAAGALR3 | |
| SCHEMBL344240 | 0.85 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDGAAGALR3 | |
| SCHEMBL21899538 | 0.82 | TSHR (0.48) | ALDH1A1KDM4EHPGDGAAGALR3 | |
| SCHEMBL15832013 | 0.81 | AR (0.47) | ALDH1A1KDM4EHPGDNPSR1MAPT | |
| SCHEMBL15832012 | 0.81 | CYP19A1 (0.50) | ALDH1A1KDM4EGAACYP1A2CYP2C9 | |
| SCHEMBL22420407 | 0.80 | CYP11B1 (0.51) | ALDH1A1KDM4EHPGDGAAGALR3 | |
| SCHEMBL15832016 | 0.80 | CYP2A6 (0.47) | ALDH1A1KDM4EHPGDGAACYP1A2 | |
| SCHEMBL2775591 | 0.79 | MAP2K4 (0.43) | PIM1MAOAMAOBARCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858949-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-11858949-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-20200392173-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-12-17 | — | — | US | disclosed |
| US-10806720-B2 | Selective androgen receptor degrader (SARD) ligands and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2020-10-20 | — | — | US | disclosed |
| WO-2020061473-A1 | SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS | JNANA THERAPEUTICS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| US-20190229276-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-25 | — | — | US | disclosed |
| US-9818952-B2 | Condensed cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-20140183468-A1 | PYRENE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-07-03 | — | — | US | disclosed |
| CN-102491862-A | Method for preparing biaryl compound in pure water | UNIV DALIAN TECH | 2012-06-13 | — | — | CN | disclosed |
| CN-101665469-A | Heterocyclic compounds useful as Nurrl activators | NOVARTIS AG | 2010-03-10 | — | — | CN | disclosed |
| CN-100475795-C | Heterocyclic compounds useful as Nurr1 activators | NOVARTIS AG (CH) | 2009-04-08 | — | — | CN | disclosed |
| CN-1747942-A | Heterocyclic compounds useful as Nurr1 activators | NOVARTIS AG (CH) | 2006-03-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190229276-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND | CRY1, CCNT1, CCND2 | ALDH1A1 1544/4885KDM4E 3333/4885HPGD 3411/4885 |
| US-20200392173-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | L1CAM, MEN1, LEF1 | ALDH1A1 97/4885KDM4E 3628/4885HPGD 4227/4885 |
| US-11858949-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | L1CAM, MEN1, LEF1 | ALDH1A1 97/4885KDM4E 3628/4885HPGD 4227/4885 |
| US-10806720-B2 | Selective androgen receptor degrader (SARD) ligands and methods of use thereof | AR, BRCA1, FSHR | ALDH1A1 2139/4885KDM4E 1050/4885HPGD 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.